Explore the words cloud of the SILICOFCM project. It provides you a very rough idea of what is the project "SILICOFCM" about.
The following table provides information about the project.
ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO
|Coordinator Country||Serbia [RS]|
|Total cost||5˙507˙441 €|
|EC max contribution||5˙507˙441 € (100%)|
1. H2020-EU.3.1.5. (Methods and data)
|Duration (year-month-day)||from 2018-06-01 to 2021-11-30|
Take a look of project's partnership.
|1||ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO||RS (KRAGUJEVAC)||coordinator||653˙000.00|
|2||UNIVERSITY OF NEWCASTLE UPON TYNE||UK (NEWCASTLE UPON TYNE)||participant||604˙090.00|
|3||UNIVERSITY OF WASHINGTON||US (SEATTLE WA)||participant||450˙201.00|
|4||INSTITUT ZA KARDIOVASKULARNE BOLESTI VOJVODINE||RS (SREMSKA KAMENICA)||participant||445˙750.00|
|5||ILLINOIS INSTITUTE OF TECHNOLOGY||US (CHICAGO IL)||participant||417˙750.00|
|6||UNIVERSITY OF KENT||UK (CANTERBURY, KENT)||participant||413˙550.00|
|7||SORBONNE UNIVERSITE||FR (PARIS)||participant||396˙625.00|
|8||KLINIKUM DER UNIVERSITAET REGENSBURG||DE (REGENSBURG)||participant||374˙625.00|
|9||BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION||ES (BARCELONA)||participant||342˙375.00|
|10||SEVEN BRIDGES GENOMICS INC||US (CAMBRIDGE MA)||participant||339˙375.00|
|11||UNIVERSITA DEGLI STUDI DI FIRENZE||IT (Florence)||participant||327˙475.00|
|12||Steinbeis Advanced Risk Technologies GmbH||DE (STUTTGART)||participant||278˙750.00|
|13||PANEPISTIMIO IOANNINON||EL (IOANNINA)||participant||276˙375.00|
|14||UNIVERZA V LJUBLJANI||SI (LJUBLJANA)||participant||187˙500.00|
According to the 2014 European Society of Cardiology Guidelines, cardiomyopathies are defined as structural and functional abnormalities of the ventricular myocardium that are unexplained by flow limiting coronary artery disease or abnormal loading conditions. There are four major classifications of cardiomyopathy: hypertrophic (HCM), dilated (DCM), restrictive (RCM), and arrhythmogenic right ventricular (ARVC). Familial cardiomyopathies (FCM) are most commonly diagnosed, or progress of the disease is monitored, through in vivo imaging, with either echocardiography or, increasingly, cardiac magnetic resonance imaging (MRI). The treatment of symptoms of FCM by established therapies could only in part improve the outcome, but novel therapies need to be developed to affect the disease process and time course more fundamentally. SILICOFCM project will develop in silico computational cloud platform which will integrate from stopped-flow molecular kinetic assays to magnetic resonance imaging of the whole heart, bioinformatics and image processing tools with state of the art computer models with the aim to reduce animal and clinical studies for a new drug development and optimized clinical therapy of FCM. The developed system will be distributed on the cloud platforms in order to achieve efficient data storage and high-performance computing, that can offer end users results in reasonably short time. Academic technical partners IIT, UOI, UL and BSC will be responsible for developing and integration of in silico cloud computational platform with multi-scale cardiac muscle modelling which include experiments on protein mutation in vitro from UNIKENT, UNIFI and UW. Bioinformatics tools will be integrated by US company SBG. Clinical partners UNEW, ICVDV, UPMC and UHREG will do retrospective and prospective studies. SME partner R-Tech will be in charge of regulatory issues and reports and BIOIRC will do the exploitation of the project.
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SILICOFCM" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SILICOFCM" are provided by the European Opendata Portal: CORDIS opendata.